Medicare Enrolled
Dr. Andreas Runheim, M.D.
Optician · Winston-Salem, NC
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Runheim from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Runheim?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Runheim
Dr. Andreas Runheim is an optician specialist in Winston-Salem, NC, with 20 years of NPI registration. Based on federal Medicare data, Dr. Runheim performed 10,847 Medicare services across 1,802 unique beneficiaries.
Between the years covered by Open Payments, Dr. Runheim received a total of $36,077 from 103 pharmaceutical and/or device companies across 2448 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Runheim is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 4% volume in NC
$36,077 industry payments
Medicare Practice Summary
Medicare Utilization ↗10,847
Medicare services
Top 4% in NC for optician
1,802
Unique beneficiaries
$26
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~542 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
5,200 | $5 | $31 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
2,113 | $1 | $30 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
984 | $84 | $212 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
779 | $71 | $321 |
| Trigger point injection, 3 or more muscles Injection of medication into three or more specific muscle trigger points to relieve pain. |
758 | $42 | $210 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
323 | $60 | $159 |
| Nerve conduction studies, 11-12 A diagnostic test that measures how well nerves send electrical signals. It involves performing 11 to 12 separate nerve conduction studies. |
275 | $176 | $781 |
| Injection, methylprednisolone acetate, 40 mg | 239 | $6 | $28 |
| Needle electromyography of trunk or head muscles A test that uses a needle electrode to measure the electrical activity of muscles in the trunk or head. This helps evaluate muscle and nerve function. |
39 | $63 | $293 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
38 | $119 | $306 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
37 | $79 | $224 |
| Injection of carpal tunnel | 30 | $77 | $199 |
| Needle EMG with jitter and fiber density testing A test that uses a needle electrode to measure the electrical activity of muscles. It specifically analyzes jitter, blocking, and fiber density to assess nerve and muscle function. |
21 | $150 | $305 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
11 | $267 | $964 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$36,077
Total received (2018-2024)
Avg $5,154/year across 7 years
Top 6% in NC for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
103
Companies
2,448
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$34,332 (95.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,465 (4.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$280 (0.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$7,363
2023
$6,307
2022
$5,083
2021
$4,720
2020
$4,336
2019
$4,585
2018
$3,684
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Medtronic, Inc.
$1,585
UCB, Inc.
$718
ABBVIE INC.
$692
Teva Pharmaceuticals USA, Inc.
$595
PFIZER INC.
$411
Biogen, Inc.
$348
Lilly USA, LLC
$307
ARGENX US, INC.
$298
Eisai Inc.
$276
ACADIA Pharmaceuticals Inc
$193
EMD Serono, Inc.
$188
Lundbeck LLC
$188
ANI Pharmaceuticals, Inc.
$170
Neurelis, Inc.
$158
Neurocrine Biosciences, Inc.
$141
Celgene Corporation
$137
Takeda Pharmaceuticals U.S.A., Inc.
$134
Otsuka America Pharmaceutical, Inc.
$132
MDD US Operations, LLC
$113
Sumitomo Pharma America, Inc.
$97
Amgen Inc.
$83
TG Therapeutics, Inc.
$81
SK Life Science, Inc.
$55
Novartis Pharmaceuticals Corporation
$46
Alexion Pharmaceuticals, Inc.
$44
Collegium Pharmaceutical, Inc.
$38
SCILEX PHARMACEUTICALS INC.
$36
Mallinckrodt Hospital Products Inc.
$26
JAZZ PHARMACEUTICALS INC.
$21
Genentech USA, Inc.
$20
Grifols USA, LLC
$18
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$15
Top 3 companies account for 40.7% of 2024 payments
All-time payments by company (2018-2024) ›
Supernus Pharmaceuticals, Inc.
$2,681
Sunovion Pharmaceuticals Inc.
$2,429
Biogen, Inc.
$2,101
Teva Pharmaceuticals USA, Inc.
$2,084
ARGENX US, INC.
$1,894
UCB, Inc.
$1,826
Medtronic, Inc.
$1,620
ABBVIE INC.
$1,475
EMD Serono, Inc.
$1,423
Novartis Pharmaceuticals Corporation
$1,163
AbbVie Inc.
$1,112
PFIZER INC.
$1,106
Allergan, Inc.
$806
Alexion Pharmaceuticals, Inc.
$722
Lundbeck LLC
$659
Lilly USA, LLC
$606
SK Life Science, Inc.
$590
ACADIA Pharmaceuticals Inc
$563
Neurocrine Biosciences, Inc.
$549
Amgen Inc.
$513
GENZYME CORPORATION
$472
Biohaven Pharmaceutical Holding Company Ltd.
$454
Neurelis, Inc.
$393
Eisai Inc.
$387
Grifols USA, LLC
$382
Allergan Inc.
$368
Biohaven Pharmaceuticals, Inc.
$364
Mallinckrodt Hospital Products Inc.
$348
Janssen Pharmaceuticals, Inc
$323
MDD US Operations, LLC
$320
US WorldMeds, LLC
$315
Greenwich Biosciences, Inc.
$315
Adamas Pharmaceuticals, Inc.
$308
Celgene Corporation
$300
Mallinckrodt LLC
$262
Sumitomo Pharma America, Inc.
$231
Takeda Pharmaceuticals U.S.A., Inc.
$227
Genentech USA, Inc.
$213
IMPEL PHARMACEUTICALS INC.
$207
ANI Pharmaceuticals, Inc.
$189
Forte Bio-Pharma LLC
$174
Assertio Therapeutics, Inc.
$166
CSL Behring
$152
Otsuka America Pharmaceutical, Inc.
$149
EISAI INC.
$146
ASSERTIO THERAPEUTICS, Inc.
$142
Horizon Therapeutics plc
$136
Collegium Pharmaceutical, Inc.
$119
Merz Pharmaceuticals, LLC
$117
E.R. Squibb & Sons, L.L.C.
$115
Corium, LLC
$113
JAZZ PHARMACEUTICALS INC.
$112
Amneal Pharmaceuticals LLC
$97
Axsome Therapeutics, Inc.
$97
Scilex Pharmaceuticals Inc.
$95
Banner Life Sciences, LLC
$87
Harmony Biosciences LLC
$84
TG Therapeutics, Inc.
$81
Upsher-Smith Laboratories LLC
$79
Avion Pharmaceuticals
$78
Kyowa Kirin, Inc.
$78
Genentech, Inc.
$68
Mitsubishi Tanabe Pharma America, Inc.
$62
Promius Pharma LLC
$61
Ipsen Biopharmaceuticals, Inc
$59
Acorda Therapeutics, Inc
$59
Jazz Pharmaceuticals Inc.
$56
Daiichi Sankyo Inc.
$55
Boston Scientific Corporation
$54
Sentynl Therapeutics, Inc.
$52
HOSPIRA, INC.
$51
UPSHER-SMITH LABORATORIES LLC
$51
TG THERAPEUTICS, INC.
$48
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$48
SCILEX PHARMACEUTICALS INC.
$48
ARBOR PHARMACEUTICALS, INC.
$46
Merck Sharp & Dohme Corporation
$45
LivaNova USA, Inc.
$40
GE HEALTHCARE
$30
Strongbridge US INC.
$28
Xeris Pharmaceuticals, Inc.
$27
Impax Laboratories, Inc.
$26
Avanir Pharmaceuticals, Inc.
$25
BioDelivery Sciences International, Inc.
$24
BioMarin Pharmaceutical Inc.
$23
Akcea Therapeutics, Inc.
$23
GlaxoSmithKline, LLC.
$22
AQUESTIVE THERAPEUTICS, INC.
$17
Abbott Laboratories
$17
Zogenix Inc.
$17
Cala Health, Inc.
$16
CATALYST PHARMACEUTICALS, INC.
$16
GRT US Holding, Inc.
$16
Egalet US Inc
$14
Mallinckrodt Enterprises LLC
$14
GE Healthcare
$14
BOSTON SCIENTIFIC CORPORATION
$14
Zyla Life Sciences
$13
Currax Pharmaceuticals LLC
$12
Merck Sharp & Dohme LLC
$12
Bausch Health US, LLC
$12
Vertical Pharmaceuticals, LLC
$12
Arbor Pharmaceuticals, Inc.
$11
Top 3 companies account for 20.0% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMYVID · ANORO · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adlarity · Aimovig · Austedo XR · BAFIERTAM · BELSOMRA · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · BUNAVAIL 2.1 mg 30-count box · BYSTOLIC · Belbuca · Brineura · Briviact · CALA TRIO · COMIRNATY · CONTRAVE · COPAXONE · Cambia · DUOPA · DYSPORT · Dhivy · ELYXYB - CELECOXIB · ELYXYB - celecoxib · EMBEDA · EMGALITY · EPIDIOLEX · Epidiolex · FIRDAPSE · Fintepla · Fycompa · GAMMAGARD · GENERAL PAIN MANAGEMENT · GENERAL - PAIN MANAGEMENT · GENERAL PAIN MANAGEMENT · GILENYA · GOCOVRI · Gamunex-C · Gocovri · Gralise · HYQVIA · Hizentra · Horizant · INBRIJA · INGREZZA · INTELLIS ADAPTIVESTIM · Infinity DBS Pulse Generators · KESIMPTA · KEVEYIS · KISUNLA · KYNMOBI · LEMTRADA · LEQEMBI · LINZESS · LYRICA · Leqembi · Levorphanol · MAVENCLAD · MAYZENT · MIGRANAL · MYOBLOC · Mavenclad · Morphabond ER · NALOCET · NAMZARIC · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nalocet · Nayzilam · Neupro · Nourianz · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · OXTELLAR XR · Ocrevus · Ongentys · PANZYGA · PAXLOVID · PURIFIED CORTROPHIN GEL · Ponvory · QELBREE · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · Qutenza · RAYOS · RELEXXII · RELISTOR · REXULTI · RYTARY · Radicava · Rebif · Rystiggo · SOLIRIS · SPRIX · SYMPAZAN · Soliris · Sunosi · TECFIDERA · TEGSEDI · TEPEZZA · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS Therapy · VRAYLAR · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · Wakix · XADAGO · XARELTO · XTAMPZA · XYWAV · Xadago · Xeomin · Xyrem · ZAVZPRET · ZEMBRACE SYMTOUCH · ZEPOSIA · ZIPSOR · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zembrace · Zembrace SymTouch Sumatriptan Injection · Zilbrysq
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (95%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 6% for optician in NC.
Geographic Context
Opticians within 10 mi
79
Per 100K population
20.4
County median income
$65,541
Nearest hospital
NOVANT HEALTH FORSYTH MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Runheim is a mixed practice specialist, with above-average Medicare volume (top 4% in NC), with low-engagement industry engagement in the top 6% of NC peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Runheim experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Runheim performed 5,200 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Runheim receive payments from pharmaceutical companies?
Yes. Dr. Runheim received a total of $36,077 from 103 companies across 2,448 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Runheim's costs compare to other opticians in Winston-Salem?
Dr. Runheim's average Medicare payment per service is $26. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Runheim) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Winston-Salem
Browse opticians in Winston-Salem ranked by procedure volume and transparency data.
Highest volume
Top Opticians in NC
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in NC
Which NC opticians receive the most from drug and device companies.
By company
Supernus Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Supernus Pharmaceuticals, Inc.
By company
Sunovion Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Sunovion Pharmaceuticals Inc.
By company
Biogen, Inc. Payments to Doctors
See all physicians who received payments from Biogen, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology